{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:02:04Z","timestamp":1787180524789,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research Grants Council General Research Fund","award":["17114921"],"award-info":[{"award-number":["17114921"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The influence of maternal levothyroxine treatment during pregnancy remains unclear. This study aimed to evaluate the associations of maternal levothyroxine treatment during pregnancy with the birth and neurodevelopmental outcomes in offspring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This population-based cohort study was conducted among pregnant women using the Hong Kong Clinical Data Analysis and Reporting System. Mother-child pairs in Hong Kong from 2001 to 2015 were included and children were followed up till 2020. We defined the exposure group as mothers who were exposed to levothyroxine during pregnancy. Preterm birth and small for gestational age (SGA) were included as birth outcomes. Attention-deficit\/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) were included as neurodevelopmental outcomes. Odds ratios (OR) or hazard ratios (HRs) with a 95% confidence interval (CI) were evaluated to assess the association of gestational levothyroxine use with offspring birth and neurodevelopmental outcomes respectively, using propensity score fine-stratification weighting and a Cox proportional hazards regression model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 422,156 mother-child pairs, 2125 children were born from mothers exposed to levothyroxine during pregnancy. A significantly increased risk of preterm birth was observed in children with maternal levothyroxine exposure during pregnancy, when compared to mothers who had no history of thyroid-related diagnoses or prescriptions (weighted OR [wOR]: 1.22, 95% CI: 1.07, 1.39). Similarly, an increased risk of preterm birth was found among children of gestational levothyroxine users, when compared to children of mothers who had used levothyroxine before but stopped during pregnancy (wOR: 2.16, 95% CI: 1.09, 4.25). Sensitivity analysis, by excluding mothers exposed to psychotropic or antiepileptic medications before or during pregnancy, also indicated a similar increased risk of preterm birth regarding the gestational use of levothyroxine (wOR: 1.26, 95% CI: 1.10, 1.45). No significant association was observed for the risk of SGA, ADHD, and ASD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There is no evidence that gestational use of levothyroxine is associated with SGA, ADHD, or ASD in offspring. Gestational levothyroxine treatment is associated with a higher risk of preterm birth. Such risk might be confounded by the underlying maternal thyroid disease itself, however, we cannot completely exclude the possible effect of gestational L-T4 treatment on offspring preterm birth. Our findings provided support to the current guidelines on the cautious use of levothyroxine treatment during pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-022-02586-9","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T20:02:27Z","timestamp":1667851347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of maternal levothyroxine use during pregnancy with offspring birth and neurodevelopmental outcomes: a population-based cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Grace Mengqin","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund C. L.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K. C.","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Cheong","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria H. Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie W. C.","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Lung","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C. K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"issue":"19","key":"2586_CR1","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1001\/jama.2019.5321","volume":"321","author":"LT Dickens","year":"2019","unstructured":"Dickens LT, Cifu AS, Cohen RN. Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum Period. JAMA. 2019;321(19):1928\u20139.","journal-title":"JAMA."},{"issue":"3","key":"2586_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/thy.2016.0457","volume":"27","author":"EK Alexander","year":"2017","unstructured":"Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315\u201389.","journal-title":"Thyroid."},{"issue":"2","key":"2586_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000362597","volume":"3","author":"J Lazarus","year":"2014","unstructured":"Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B. 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014;3(2):76\u201394.","journal-title":"Eur Thyroid J"},{"issue":"10","key":"2586_CR4","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1089\/thy.2011.0087","volume":"21","author":"A Stagnaro-Green","year":"2011","unstructured":"Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10):1081\u2013125.","journal-title":"Thyroid."},{"issue":"1","key":"2586_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ecl.2005.09.009","volume":"35","author":"SO LeBeau","year":"2006","unstructured":"LeBeau SO, Mandel SJ. Thyroid disorders during pregnancy. Endocrinol Metab Clin N Am. 2006;35(1):117\u201336 vii.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"2586_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00003081-199703000-00007","volume":"40","author":"JH Mestman","year":"1997","unstructured":"Mestman JH. Hyperthyroidism in pregnancy. Clin Obstet Gynecol. 1997;40(1):45\u201364.","journal-title":"Clin Obstet Gynecol"},{"issue":"3","key":"2586_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1210\/edrv.18.3.0300","volume":"18","author":"D Glinoer","year":"1997","unstructured":"Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 1997;18(3):404\u201333.","journal-title":"Endocr Rev"},{"issue":"1","key":"2586_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJM198907063210103","volume":"321","author":"T Vulsma","year":"1989","unstructured":"Vulsma T, Gons MH, de Vijlder JJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med. 1989;321(1):13\u20136.","journal-title":"N Engl J Med"},{"issue":"1","key":"2586_CR9","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1530\/EJE-16-0947","volume":"177","author":"SL Andersen","year":"2017","unstructured":"Andersen SL, Carle A, Karmisholt J, Pedersen IB, Andersen S. MECHANISMS IN ENDOCRINOLOGY: Neurodevelopmental disorders in children born to mothers with thyroid dysfunction: evidence of fetal programming? Eur J Endocrinol. 2017;177(1):R27\u201336.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2586_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/105072502753451986","volume":"12","author":"M Abalovich","year":"2002","unstructured":"Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12(1):63\u20138.","journal-title":"Thyroid."},{"issue":"7","key":"2586_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/ncpendmet0846","volume":"4","author":"K Poppe","year":"2008","unstructured":"Poppe K, Velkeniers B, Glinoer D. The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab. 2008;4(7):394\u2013405.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"2","key":"2586_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0040-1717073","volume":"38","author":"MR Peltier","year":"2021","unstructured":"Peltier MR, Fassett MJ, Chiu VY, Getahun D. Maternal Hypothyroidism Increases the Risk of Attention-Deficit Hyperactivity Disorder in the Offspring. Am J Perinatol. 2021;38(2):191\u2013201.","journal-title":"Am J Perinatol"},{"issue":"3","key":"2586_CR13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/pr.2017.308","volume":"83","author":"D Getahun","year":"2018","unstructured":"Getahun D, Jacobsen SJ, Fassett MJ, Wing DA, Xiang AH, Chiu VY, et al. Association between maternal hypothyroidism and autism spectrum disorders in children. Pediatr Res. 2018;83(3):580\u20138.","journal-title":"Pediatr Res"},{"key":"2586_CR14","doi-asserted-by":"crossref","unstructured":"Ge GM, Leung MTY, Man KKC, Leung WC, Ip P, Li GHY, et al. Maternal Thyroid Dysfunction During Pregnancy and the Risk of Adverse Outcomes in the Offspring: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2020;105(12):dgaa555.","DOI":"10.1210\/clinem\/dgaa555"},{"issue":"9","key":"2586_CR15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1056\/NEJMoa1606205","volume":"376","author":"BM Casey","year":"2017","unstructured":"Casey BM, Thom EA, Peaceman AM, Varner MW, Sorokin Y, Hirtz DG, et al. Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy. N Engl J Med. 2017;376(9):815\u201325.","journal-title":"N Engl J Med"},{"issue":"6","key":"2586_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1106104","volume":"366","author":"JH Lazarus","year":"2012","unstructured":"Lazarus JH, Bestwick JP, Channon S, Paradice R, Maina A, Rees R, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012;366(6):493\u2013501.","journal-title":"N Engl J Med"},{"issue":"4","key":"2586_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1089\/ct.2017;29.132-135","volume":"29","author":"JM Hershman","year":"2017","unstructured":"Hershman JM. Levothyroxine therapy of subclinical hypothyroidism or hypothyroxinemia in pregnancy does not improve cognitive function in the offspring. Clin Thyroidol. 2017;29(4):132\u20135.","journal-title":"Clin Thyroidol"},{"issue":"4","key":"2586_CR18","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1210\/jc.2009-2009","volume":"95","author":"R Negro","year":"2010","unstructured":"Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab. 2010;95(4):1699\u2013707.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2586_CR19","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1210\/jc.2005-1603","volume":"91","author":"R Negro","year":"2006","unstructured":"Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab. 2006;91(7):2587\u201391.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2586_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000343759","volume":"74","author":"T Lepoutre","year":"2012","unstructured":"Lepoutre T, Debi\u00e8ve F, Gruson D, Daumerie C. Reduction of miscarriages through universal screening and treatment of thyroid autoimmune diseases. Gynecol Obstet Investig. 2012;74(4):265\u201373.","journal-title":"Gynecol Obstet Investig"},{"issue":"10","key":"2586_CR21","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1210\/jc.2016-1803","volume":"101","author":"R Negro","year":"2016","unstructured":"Negro R, Schwartz A, Stagnaro-Green A. Impact of Levothyroxine in Miscarriage and Preterm Delivery Rates in First Trimester Thyroid Antibody-Positive Women With TSH Less Than 2.5 mIU\/L. J Clin Endocrinol Metab. 2016;101(10):3685\u201390.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2586_CR22","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2017.1363","volume":"317","author":"WC Lau","year":"2017","unstructured":"Lau WC, Chan EW, Cheung CL, Sing CW, Man KK, Lip GY, et al. Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation. JAMA. 2017;317(11):1151\u20138.","journal-title":"JAMA."},{"issue":"1","key":"2586_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/M19-3671","volume":"173","author":"WCY Lau","year":"2020","unstructured":"Lau WCY, Cheung CL, Man KKC, Chan EW, Sing CW, Lip GYH, et al. Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A Population-Based Cohort Study. Ann Intern Med. 2020;173(1):1\u20139.","journal-title":"Ann Intern Med"},{"issue":"3","key":"2586_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7326\/M21-3700","volume":"175","author":"FTT Lai","year":"2022","unstructured":"Lai FTT, Li X, Peng K, Huang L, Ip P, Tong X, et al. Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine: A Case\u2013Control Study. Ann Intern Med. 2022;175(3):362\u201370.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2586_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1473-3099(21)00451-5","volume":"22","author":"EYF Wan","year":"2022","unstructured":"Wan EYF, Chui CSL, Lai FTT, Chan EWY, Li X, Yan VKC, et al. Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis. 2022;22(1):64\u201372.","journal-title":"Lancet Infect Dis"},{"key":"2586_CR26","doi-asserted-by":"crossref","unstructured":"Wang Z, Chan AYL, Coghill D, Ip P, Lau WCY, Simonoff E, et al. Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit\/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age. JAMA Intern Med. 2021;181(10):1332-40.","DOI":"10.1001\/jamainternmed.2021.4571"},{"issue":"2","key":"2586_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/wps.20948","volume":"21","author":"Z Wang","year":"2022","unstructured":"Wang Z, Chan AYL, Ho PWH, Wong KHTW, Brauer R, Besag FMC, et al. Prenatal exposure to antidepressants or antipsychotics and the risk of seizure in children. World Psychiatry. 2022;21(2):322\u20133.","journal-title":"World Psychiatry"},{"key":"2586_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2350","volume":"357","author":"KKC Man","year":"2017","unstructured":"Man KKC, Chan EW, Ip P, Coghill D, Simonoff E, Chan PKL, et al. Prenatal antidepressant use and risk of attention-deficit\/hyperactivity disorder in offspring: population based cohort study. BMJ. 2017;357:j2350.","journal-title":"BMJ."},{"issue":"14","key":"2586_CR29","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1177\/1087054714536047","volume":"21","author":"KKC Man","year":"2017","unstructured":"Man KKC, Ip P, Hsia Y, Chan EW, Chui CSL, Lam MPS, et al. ADHD drug prescribing trend is increasing among children and adolescents in Hong Kong. J Atten Disord. 2017;21(14):1161\u20138.","journal-title":"J Atten Disord"},{"issue":"7","key":"2586_CR30","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s40263-021-00824-x","volume":"35","author":"L Gao","year":"2021","unstructured":"Gao L, Man KKC, Chan EW, Chui CSL, Li X, Coghill D, et al. Treatment with methylphenidate for attention deficit hyperactivity disorder (ADHD) and the risk of all-cause poisoning in children and adolescents: a self-controlled case series study. CNS Drugs. 2021;35(7):769\u201379.","journal-title":"CNS Drugs"},{"issue":"4","key":"2586_CR31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/thy.2017.0425","volume":"28","author":"SL Andersen","year":"2018","unstructured":"Andersen SL, Andersen S, Vestergaard P, Olsen J. Maternal thyroid function in early pregnancy and child neurodevelopmental disorders: a Danish nationwide case-cohort study. Thyroid. 2018;28(4):537\u201346.","journal-title":"Thyroid."},{"issue":"8","key":"2586_CR32","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/jamapsychiatry.2018.0854","volume":"75","author":"GM Maher","year":"2018","unstructured":"Maher GM, O\u2019Keeffe GW, Kearney PM, Kenny LC, Dinan TG, Mattsson M, et al. Association of hypertensive disorders of pregnancy with risk of neurodevelopmental disorders in offspring: a systematic review and meta-analysis. JAMA Psychiatry. 2018;75(8):809\u201319.","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"2586_CR33","first-page":"104","volume":"3","author":"A Ornoy","year":"2005","unstructured":"Ornoy A. Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes. Pediatr Endocrinol Rev. 2005;3(2):104\u201313.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"4","key":"2586_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/01.yco.0000079218.36371.78","volume":"16","author":"TJ Leverton","year":"2003","unstructured":"Leverton TJ. Parental psychiatric illness: the implications for children. Curr Opin Psychiatry. 2003;16(4):395\u2013402.","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"2586_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41\u201355.","journal-title":"Biometrika."},{"key":"2586_CR36","doi-asserted-by":"crossref","unstructured":"Desai RJ, Franklin JM. Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. BMJ. 2019;367:i5657.","DOI":"10.1136\/bmj.l5657"},{"issue":"2","key":"2586_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/EDE.0000000000000595","volume":"28","author":"RJ Desai","year":"2017","unstructured":"Desai RJ, Rothman KJ, Bateman BT, Hernandez-Diaz S, Huybrechts KF. A Propensity score based fine stratification approach for confounding adjustment when exposure is infrequent. Epidemiology (Cambridge, Mass). 2017;28(2):249.","journal-title":"Epidemiology (Cambridge, Mass)"},{"issue":"6","key":"2586_CR38","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/ejcts\/ezy167","volume":"53","author":"U Benedetto","year":"2018","unstructured":"Benedetto U, Head SJ, Angelini GD, Blackstone EH. Statistical primer: propensity score matching and its alternatives. Eur J Cardiothorac Surg. 2018;53(6):1112\u20137.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"2586_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/jamapediatrics.2015.3356","volume":"170","author":"T Boukhris","year":"2016","unstructured":"Boukhris T, Sheehy O, Mottron L, Berard A. Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children. JAMA Pediatr. 2016;170(2):117\u201324.","journal-title":"JAMA Pediatr"},{"issue":"1","key":"2586_CR40","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6606","volume":"2","author":"J Christensen","year":"2019","unstructured":"Christensen J, Pedersen L, Sun Y, Dreier JW, Brikell I, Dalsgaard S. Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit\/Hyperactivity Disorder in Offspring. JAMA Netw Open. 2019;2(1):e186606.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2586_CR41","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1210\/jc.2006-2017","volume":"92","author":"PE Clayton","year":"2007","unstructured":"Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A. Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab. 2007;92(3):804\u201310.","journal-title":"J Clin Endocrinol Metab"},{"key":"2586_CR42","doi-asserted-by":"crossref","unstructured":"Sibai BM. Preeclampsia as a cause of preterm and late preterm (near-term) births. Semin Perinatol. 2006;30(1):16-9.","DOI":"10.1053\/j.semperi.2006.01.008"},{"issue":"1","key":"2586_CR43","doi-asserted-by":"publisher","first-page":"e0169542-e","DOI":"10.1371\/journal.pone.0169542","volume":"12","author":"LE Johns","year":"2017","unstructured":"Johns LE, Ferguson KK, McElrath TF, Mukherjee B, Seely EW, Meeker JD. Longitudinal Profiles of Thyroid Hormone Parameters in Pregnancy and Associations with Preterm Birth. PLoS One. 2017;12(1):e0169542-e.","journal-title":"PLoS One"},{"issue":"5","key":"2586_CR44","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1089\/thy.2020.0609","volume":"31","author":"P Lemieux","year":"2021","unstructured":"Lemieux P, Yamamoto JM, Nerenberg KA, Metcalfe A, Chin A, Khurana R, et al. Thyroid Laboratory Testing and Management in Women on Thyroid Replacement Before Pregnancy and Associated Pregnancy Outcomes. Thyroid. 2021;31(5):841\u20139.","journal-title":"Thyroid."},{"issue":"11","key":"2586_CR45","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1210\/jc.2015-3074","volume":"100","author":"PM Sheehan","year":"2015","unstructured":"Sheehan PM, Nankervis A, Araujo J\u00fanior E, Da Silva CF. Maternal thyroid disease and preterm birth: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(11):4325\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"2586_CR46","doi-asserted-by":"crossref","unstructured":"Ding Z, Liu Y, Maraka S, Abdelouahab N, Huang H-F, Fraser WD, et al. Pregnancy and neonatal outcomes with levothyroxine treatment in women with subclinical hypothyroidism based on new diagnostic criteria: a systematic review and meta-analysis. Front Endocrinol. 2021;12:797423.","DOI":"10.3389\/fendo.2021.797423"},{"issue":"3","key":"2586_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/108705470200500302","volume":"5","author":"J Gershon","year":"2002","unstructured":"Gershon J, Gershon J. A meta-analytic review of gender differences in ADHD. J Atten Disord. 2002;5(3):143\u201354.","journal-title":"J Atten Disord"},{"issue":"3","key":"2586_CR48","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.rasd.2010.12.003","volume":"5","author":"TT Rivet","year":"2011","unstructured":"Rivet TT, Matson JL. Review of gender differences in core symptomatology in autism spectrum disorders. Res Autism Spectr Disord. 2011;5(3):957\u201376.","journal-title":"Res Autism Spectr Disord"},{"issue":"10","key":"2586_CR49","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/thy.2000.10.871","volume":"10","author":"D Glinoer","year":"2000","unstructured":"Glinoer D, Delange F. The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid. 2000;10(10):871\u201387.","journal-title":"Thyroid."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02586-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02586-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02586-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T20:02:47Z","timestamp":1667851367000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02586-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2586"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02586-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742400567.793596938","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"7 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Institutional Review Board of the University of Hong Kong\/Hospital Authority Hong Kong West Cluster for CDARS database research (Reference Number: UW 20-166).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KM reported grants from C W Maplethorpe during the conduct of the study as well as grants from the National Institute of Health Research, European Commission Framework Horizon 2020, Hong Kong Research Grant Council (RGC), the Laboratory of Data Discovery for Health by the Hong Kong Government InnoHK initiative and personal fees from IQVIA outside the submitted work. IW reported research funding from the Hong Kong Research Grants Council, the European Commission, and the Laboratory of Data Discovery for Health by the Hong Kong Government InnoHK initiative. PI reported funding from the RGC, Health and Medical Research Fund (HMRF), and Hong Kong Jockey Club Charities Trust. CLC received research grants and the honorarium from Amgen, research grant support from HMRF, and the honorarium from Abbott. The other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"390"}}